Susquehanna International Group’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-90,669
Closed -$224K 13629
2025
Q1
$224K Buy
90,669
+55,845
+160% +$133K ﹤0.01% 10712
2024
Q4
$109K Buy
34,824
+6,688
+24% +$32.4K ﹤0.01% 11269
2024
Q3
$139K Sell
28,136
-4,344
-13% -$22.4K ﹤0.01% 10811
2024
Q2
$143K Sell
32,480
-42,107
-56% -$197K ﹤0.01% 10740
2024
Q1
$503K Buy
74,587
+51,491
+223% +$391K ﹤0.01% 8504
2023
Q4
$172K Buy
23,096
+9,691
+72% +$82.7K ﹤0.01% 10831
2023
Q3
$136K Sell
13,405
-36,245
-73% -$770K ﹤0.01% 10648
2023
Q2
$1.04M Buy
+49,650
New +$1.02M ﹤0.01% 6579

Other funds holding SLRN

Susquehanna International Group's SLRN Position: Q2 2025 in Review

Susquehanna International Group sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 90,669 shares — an estimated $224K sold.

Susquehanna International Group first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $1.04M in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Susquehanna International Group reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 90,669 ACELYRIN shares in Q2 2025, an estimated $224K.
  • Susquehanna International Group first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
  • Susquehanna International Group's ACELYRIN position peaked at $1.04M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.